Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital

Ítems similars

• Regional variation of the off-licence use of rFVIIa for patients with uncontrolled haemorrhage in England
  per: Spivey, MH, et al.
  Publicat: (2010)
• Recombinant activated factor VII as treatment for uncontrolled mucosal haemorrhage
  per: Gracia, J, et al.
  Publicat: (2011)
• Analysis of red cell transfusion practices in patients without active haemorrhage over a 12-month period in a UK intensive care unit
  per: Eve, RL, et al.
  Publicat: (2010)
• The Australian and New Zealand Haemostasis Registry: ten years of data on off-licence use of recombinant activated factor VII
  per: Zatta, Amanda, et al.
  Publicat: (2015)
• Recombinant activated factor VII in post partum haemorrhage
  per: Magon, Navneet, et al.
  Publicat: (2013)